| Description | CEP295 Human Pre-designed siRNA Set A contains three designed siRNAs for CEP295 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control. Components CEP295 siRNA-1: 5 nmol (HPLC) CEP295 siRNA-2: 5 nmol (HPLC) CEP295 siRNA-3: 5 nmol (HPLC) siRNA Negative CEP295 Human Pre-designed siRNA Set A contains three designed siRNAs for CEP295 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control. Components CEP295 siRNA-1: 5 nmol (HPLC) CEP295 siRNA-2: 5 nmol (HPLC) CEP295 siRNA-3: 5 nmol (HPLC) siRNA Negative Control: 5 nmol (HPLC) FAM-labeled siRNA Negative Control: 5 nmol (HPLC) GAPDH siRNA Positive Control:5 nmol (HPLC)... Read More | Amino Acid Sequence Asn-Ser-Lys-Met-Ala-His-S?er-Ser-Ser-Cys-Phe-Gly-Gl?n-Lys-Ile-Asp-Arg-Ile-Gly?-Ala-Val-Ser-Arg-Leu-Gly-?Cys-Asp-Gly-Leu-Arg-Leu-P?he | Inquire | Proteasome-activating peptide 1 TFA is a peptide and a potent proteasome activator. Proteasome-activating peptide 1 TFA increases the chymotrypsin-like proteasomal catalytic activity and, consequently, proteolytic rates both in vitro and in culture. Proteasome-activating peptide 1 TFA prevents Proteasome-activating peptide 1 TFA is a peptide and a potent proteasome activator. Proteasome-activating peptide 1 TFA increases the chymotrypsin-like proteasomal catalytic activity and, consequently, proteolytic rates both in vitro and in culture. Proteasome-activating peptide 1 TFA prevents protein aggregation in a cellular model of amyotrophic lateral sclerosis... Read More | Purity>95% (SDS-PAGE) Endotoxin level<1.0 EU/µgFunctionInhibits the synthesis of a number of cytokines, including IFN-gamma, IL-2, IL-3, TNF and GM-CSF produced by activated macrophages and by helper T-cells |